1. Long‐term outcomes and predictors of morbi‐mortality according to age in stemi patients with multivessel disease: Impact of an incomplete revascularization
- Author
-
Pablo Almela, Salvador Morell, Dario Sanmiguel, Ernesto Valero, Alberto Berenguer, Lorenzo Fácila, Andres Cubillos, Juan Vicente Vilar, and Eva Rumiz
- Subjects
Male ,medicine.medical_specialty ,Multivariate analysis ,medicine.medical_treatment ,Coronary Artery Disease ,030204 cardiovascular system & hematology ,Coronary Angiography ,Revascularization ,Risk Assessment ,03 medical and health sciences ,Percutaneous Coronary Intervention ,0302 clinical medicine ,Risk Factors ,Internal medicine ,Incomplete revascularization ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Prospective Studies ,cardiovascular diseases ,030212 general & internal medicine ,Myocardial infarction ,Aged ,Aged, 80 and over ,Ejection fraction ,business.industry ,Incidence (epidemiology) ,General Medicine ,Multivessel disease ,Middle Aged ,medicine.disease ,Treatment Outcome ,ST Elevation Myocardial Infarction ,Female ,Cardiology and Cardiovascular Medicine ,business ,Mace - Abstract
BACKGROUND Optimal management strategy for patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease (MVD) still remains unclear, especially in the elderly population. The aim of this study was to assess long-term outcomes and predictors of morbi-mortality according to age in patients with a STEMI and MVD. METHODS We prospectively included 381 consecutive patients with a STEMI who underwent primary angioplasty and showed MVD in the angiogram. 111 (29.1%) patients were older than 75 (≥75) years and 270 (70.9%) were younger than 75 (
- Published
- 2018
- Full Text
- View/download PDF